Peripheral Vascular Devices Market

The peripheral vascular devices market is projected to reach USD 13.22 billion by 2031 from USD 10.02 billion in 2026, at a CAGR of 5.7% from 2026 to 2031.

The global market for peripheral vascular devices is growing due to the rising prevalence of vascular disorders, such as peripheral artery disease (PAD) and deep vein thrombosis (DVT). These conditions are largely attributed to an aging population, increasing rates of diabetes, obesity, and smoking. Additionally, advancements in minimally invasive endovascular surgery, including drug-coated balloons, stents, and atherectomy devices, are improving clinical outcomes. These techniques not only shorten hospital stays and promote quicker recovery times but also make treatments more appealing to both doctors and patients.

To know about the assumptions considered for the study download the pdf brochure

Furthermore, the rising number of catheterization laboratories and ambulatory surgical centers, along with increased awareness and early diagnosis of vascular diseases, is contributing to market growth. Ongoing innovations in products that improve deliverability, safety, and long-term effectiveness are also supporting the expansion of this market across both developed and emerging healthcare sectors.

Some of the major players in this market are Boston Scientific (US), Medtronic Plc (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), B. Braun Melsungen AG (Germany), Merit Medical Systems (US), Penumbra, Inc. (US), Koninklijke Philips (Netherlands), Stryker (US), Cordis (US), W.L. Gore & Associates (US), Biotronik Stryker (US), Endologix LLC (US), and Cook Medical (US), among others.

BOSTON SCIENTIFIC CORPORATION (US)

Boston Scientific's emergence as a significant player in the peripheral vascular devices market is largely due to its extensive and continually expanding product portfolio. This portfolio includes drug-coated balloons, drug-eluting stents, self-expanding stents, and embolic protection systems, all designed to address key clinical challenges associated with peripheral artery disease and other vascular conditions. These products offer both improved clinical outcomes and procedural efficiency. The company's commitment to research and development, combined with strategic acquisitions—such as Silk Road Medical and enhancements to its vascular device lines—has strengthened its technical expertise and market reach. This positioning enables Boston Scientific to thrive in both mature and emerging markets.

Furthermore, Boston Scientific benefits from a well-established global distribution network, strong brand recognition among healthcare professionals, and a focus on minimally invasive techniques. This alignment with the growing clinical preference for less-invasive peripheral interventions ensures the company maintains its leadership and continues to grow in this expanding segment of the medical device market.

MEDTRONIC (US)

Medtronic's strong position and growth as a leading brand in the peripheral vascular devices market can be attributed to its wide, innovative product range, including drug-coated balloons such as the IN.PACT Admiral and vascular stents. One reason these products are considered reliable is the company's substantial investment in R&D over many years. Through strategic partnerships with companies such as Covidien, Aptus Endosystems, and Ardian, Medtronic has enhanced its technical expertise. As a result, the company not only maintains its competitive edge but also improves its sales potential by offering services at lower prices than its competitors, thereby attracting more customers. Medtronic's global presence and strong brand image facilitate easy access to both developed and developing markets. The company's commitment to developing less-invasive, high-performance devices aligns with the growing demand for such interventions and contributes to higher procedure volumes. Together, these factors underpin Medtronic's dominance and continuous growth in the expanding market for peripheral vascular devices.

Abbott (US)

Abbott has established itself as a leader in the peripheral vascular devices market by focusing on dedicated research into endovascular and minimally invasive treatments for both arterial and venous procedures. The company leverages its extensive knowledge of vascular access, vessel preparation, and image-guided intervention support to develop healthcare solutions that physicians and healthcare systems can rely on.

The procedural technologies developed by Abbott enhance the efficiency and safety of medical procedures, thereby improving clinical outcomes in complex peripheral medical cases. By continually engaging in research, worldwide clinical initiatives, and the development of new treatment options, Abbott maintains its competitive edge in the market and addresses international demand for advanced treatments for peripheral artery disease (PAD) and venous disorders.

Market Ranking

The global peripheral vascular devices market exhibits moderate to high market concentration, as major multinational companies dominate with strong clinical portfolios and the ability to access numerous hospitals and physicians. Medtronic has established itself as a leading player in this market with an extensive line of vascular products, including essential treatment options such as drug-coated balloons, self-expanding stents, atherectomy solutions, and endovascular aneurysm repair products. The company maintains its market presence through ongoing product development, the creation of clinical evidence, and its international distribution network in both developed and developing nations.

Boston Scientific is another prominent competitor, offering a wide range of treatment options for complex cardiovascular cases. Its products include peripheral stents, balloon catheters, atherectomy systems, thrombectomy devices, embolic protection devices, and intravascular imaging support. Additionally, Boston Scientific is actively developing advanced pipeline products, bolstering its position in the global market.

Abbott has also become a significant player by committing to minimally invasive vascular treatments. The company supports these treatments with enabling technologies for endovascular procedures and vascular access while maintaining strong relationships with physicians and a substantial presence in hospitals. Abbott is focused on developing next-generation peripheral products to meet the growing demand for efficient and safe treatment options for peripheral artery disease (PAD) and venous conditions.
BD (Becton, Dickinson and Company) maintains its position as a leading company in vascular access and procedural support, having gained widespread recognition in this area more than in any of its other business operations.

Related Reports:

Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Angioplasty Stent, Catheters (IVUS/OCT), Plaque Modification, Vascular Closure Devices, Balloon Inflation Devices, Hemodynamic Flow Alteration), End User - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com